WallStreetZenWallStreetZen

NASDAQ: MNKD
Mannkind Corp Stock Forecast, Predictions & Price Target

Analyst price target for MNKD

Based on 2 analysts offering 12 month price targets for Mannkind Corp.
Min Forecast
$6.50+59.31%
Avg Forecast
$7.00+71.57%
Max Forecast
$7.50+83.82%

Should I buy or sell MNKD stock?

Based on 2 analysts offering ratings for Mannkind Corp.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their MNKD stock forecasts and price targets.

MNKD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-15
lockedlocked$00.00+00.00%2024-01-04

1 of 1

Forecast return on equity

Is MNKD forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.66%

Forecast return on assets

Is MNKD forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

MNKD revenue forecast

What is MNKD's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$242.9M+22.09%
Avg 2 year Forecast
$293.5M+47.53%
Avg 3 year Forecast
$342.6M+72.19%
MNKD's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

MNKD revenue growth forecast

How is MNKD forecast to perform vs Biotechnology companies and vs the US market?
Company
19.9%
Industry
37.96%
Market
10.23%
MNKD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MNKD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MNKD vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
MNKD$4.08$7.00+71.57%Strong Buy
PRTA$20.57$68.14+231.27%Buy
MIRM$23.57$52.75+123.80%Strong Buy
SRRK$13.95$25.60+83.51%Strong Buy
TARS$32.85$48.00+46.12%Buy

Mannkind Stock Forecast FAQ

Is Mannkind Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: MNKD) stock is to Strong Buy MNKD stock.

Out of 2 analysts, 1 (50%) are recommending MNKD as a Strong Buy, 1 (50%) are recommending MNKD as a Buy, 0 (0%) are recommending MNKD as a Hold, 0 (0%) are recommending MNKD as a Sell, and 0 (0%) are recommending MNKD as a Strong Sell.

If you're new to stock investing, here's how to buy Mannkind stock.

What is MNKD's revenue growth forecast for 2024-2026?

(NASDAQ: MNKD) Mannkind's forecast annual revenue growth rate of 19.9% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.96%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.23%.

Mannkind's revenue in 2024 is $198,962,000.On average, 4 Wall Street analysts forecast MNKD's revenue for 2024 to be $65,687,829,442, with the lowest MNKD revenue forecast at $64,786,795,950, and the highest MNKD revenue forecast at $67,280,051,892. On average, 4 Wall Street analysts forecast MNKD's revenue for 2025 to be $79,377,751,576, with the lowest MNKD revenue forecast at $75,752,254,568, and the highest MNKD revenue forecast at $83,072,475,648.

In 2026, MNKD is forecast to generate $92,642,576,277 in revenue, with the lowest revenue forecast at $88,156,338,090 and the highest revenue forecast at $98,378,146,617.

What is MNKD's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: MNKD) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is MNKD's Price Target?

According to 2 Wall Street analysts that have issued a 1 year MNKD price target, the average MNKD price target is $7.00, with the highest MNKD stock price forecast at $7.50 and the lowest MNKD stock price forecast at $6.50.

On average, Wall Street analysts predict that Mannkind's share price could reach $7.00 by Mar 15, 2025. The average Mannkind stock price prediction forecasts a potential upside of 71.57% from the current MNKD share price of $4.08.

What is MNKD's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: MNKD) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.